Clinical trial

A Study of Two Anti-HIV Drug Combinations in HIV-Infected Patients

NCT00002400

Drugs and interventions used in this trial

4 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Unmapped registry intervention Indinavir sulfate Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Delavirdine mesylate Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record Lamivudine Normalized identity: lamivudineView linked drug · Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record Zidovudine Normalized identity: zidovudineView linked drug · Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

A Study of Two Anti-HIV Drug Combinations in HIV-Infected Patients

Design: INTERVENTIONAL · Status: COMPLETED · Phase: NA

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusCOMPLETED

Study typeINTERVENTIONAL

Start dateUnknown

PhaseNA

Conditions

HIV Infectionsunresolved

Interventions

Indinavir sulfateDRUG

Delavirdine mesylateDRUG

LamivudineDRUG · verified · RxNorm: lamivudine

ZidovudineDRUG · verified · RxNorm: zidovudine

Sponsors & collaborators

Pharmacia and Upjohnlead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00002400 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.